PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures...(re to chemical nerve agents -- Ry...)

    -- RypVax(TM) - a recombinant dual antigen vaccine for plague


    For more information about PharmAthene, please visit www.PharmAthene.com.

About Medison Pharma Ltd.

Medison Pharma Ltd., headquartered in Petach Tikva, Israel, is a leading Israeli marketing group focused in the fields of high quality pharmaceutical, diagnostics and medical devices. With over a decade of experience, the company is uniquely placed to provide a complete A to Z spectrum of integrated services for international companies looking to enter or expand their presence in the Israeli healthcare market, as well as in Romania and Slovakia. For more information on Medison Pharma, please visit www.medisonpharma.com.

Statement on Cautionary Factors

Except for the historical information presented herein, matters discussed may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "potential"; "believe"; "anticipate"; "intend"; "plan"; "expect"; "estimate"; "could"; "may"; "should"; or similar statements are forward-looking statements. PharmAthene disclaims, however, any intent or obligation to update these forward-looking statements. Risks and uncertainties include risk associated with the reliability of the results of the studies relating to human safety and possible adverse effects resulting from the administration of the Company's product candidates, unexpected funding delays and/or reductions or elimination of U.S. government funding for one or mo
'/>"/>